Multidisciplinary consensus: a practical guide for the integration of abiraterone into clinical practice.

Woo, Henry H; Begbie, Stephen; Gogna, Kumar; Mainwaring, Paul N; Murphy, Declan G; Parnis, Francis; Steer, Christopher; Davis, Ian D

Woo, Henry H; Begbie, Stephen; Gogna, Kumar; Mainwaring, Paul N; Murphy, Declan G; Parnis, Francis; Steer, Christopher; Davis, Ian D.

Affiliation

Woo HH; Sydney Adventist Hospital, University of Sydney, Wahroonga, New South Wales, Australia.

Asia Pac J Clin Oncol ; 10(3): 228-36, 2014 Sep.

Article in En | MEDLINE | ID: mdl-25132163

Subject(s)

Androstenes/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Prostatic Neoplasms, Castration-Resistant/drug therapy; Androstenes/administration & dosage; Disease-Free Survival; Humans; Male; Quality of Life; Treatment Outcome

Key words

Zytiga; abiraterone; chemotherapy; cytochrome P450-17 (CYP17) inhibition; metastatic castration-resistant prostate cancer

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Prostatic Neoplasms, Castration-Resistant / Androstenes Type of study: Guideline Limits: Humans / Male Language: En Journal: Asia Pac J Clin Oncol Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: Australia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google